Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Opyn Health has acquired Empara, an AI-driven benefits engagement and administration platform, to create a unified, end-to-end benefits solution for self-funded health plans.
Cleveland Clinic and Axuall have entered a long-term collaboration to deploy Axuall Sync, an AI-enabled data engine designed to improve the accuracy and completeness of healthcare provider information across the health system.
b.well Connected Health announced a partnership with Google to enhance personalized health experiences by integrating real-time, AI-powered data connectivity across millions of healthcare providers and plans.
Triomics has partnered with Memorial Sloan Kettering Cancer Center to implement its AI-powered platform for automating clinical trial matching, aiming to streamline patient screening and expand access to active trials.
TetraScience has introduced its Scientific AI Lighthouse (SAIL) program, naming Takeda as the founding partner. The initiative provides Takeda early access to TetraScience’s full data and AI capabilities to accelerate drug discovery and improve R&D productivity.
Truemed and Lynx have announced a strategic partnership to build integrated e-commerce solutions for third-party administrators, benefits administrators, and health plans, enabling purchases of HSA and FSA-eligible products.
Sage Care has launched from stealth with $20 million in funding led by Yosemite, joined by General Catalyst, Metrodora, and others. The company’s AI-driven platform streamlines healthcare operations through intelligent triage, scheduling, and patient-provider matching.
Offline Studio has partnered with Corundum Neuroscience and Corundum Systems Biology to create a new venture initiative that will develop life sciences products using data from the Human Phenotype Project.
eHealth Technologies has released a Forrester Consulting study showing that healthcare systems using its eHealth Connect platform achieved $5.9 million in quantified benefits and a 93% ROI over three years.
InnerScope Hearing Technologies has announced a strategic alliance with Ainnova Tech as part of Ainnova's acquisition of OTCHealth Inc., transitioning retail operations to the new subsidiary and focusing on global R&D and hearing technology innovation.
Abundant Venture Partners has grown its Alliance to 22 healthcare provider organizations and introduced a new pediatric cohort to co-develop innovations in pediatric care.
Honey Health has secured $7.8 million in seed funding led by Pelion Ventures to expand its AI platform that automates back-office workflows for healthcare organizations.
Altius has announced a multi-year, $1 billion partnership with UK-based Syd Life AI to introduce a personalized AI preventive care platform in the U.S., leveraging technology validated by the NHS.
The global healthcare quality management market is projected to grow from $1.42 billion in 2025 to $2.51 billion by 2030, driven by the increasing use of AI, machine learning, and predictive analytics to improve clinical and operational outcomes.
Moberg Analytics has secured $600,000 in seed funding to accelerate commercialization of its Moberg Clinical Platform, a software system that integrates multimodal brain data for intensive care units.
Chromatin Bioscience has announced a research collaboration with Purespring Therapeutics to develop synthetic promoters that enable precise gene expression for kidney disease therapies.
REPROCELL USA has received funding from the Maryland Stem Cell Research Fund to develop a GMP-grade Contract Development and Manufacturing Organization in Maryland, expanding its stem cell manufacturing capabilities.
Region Stockholm and Region Gotland will unify all hospital imaging under Sectra's fully managed cloud service, streamlining collaboration and improving security across departments.
Bahrain’s sovereign wealth fund Mumtalakat has entered a strategic partnership with SandboxAQ to develop a biotech ecosystem using AI and quantum technologies. The three-year collaboration aims to generate over $1 billion in biotech value for the Kingdom.
YorLabs has received FDA 510(k) clearance for its Intracardiac Imaging System, a zero-capex ultrasound platform designed for electrophysiology and interventional cardiology procedures. The system enables single-operator control and offers high-resolution, real-time imaging for cardiac interventions.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
